ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Intellia Therapeutics Inc

Intellia Therapeutics Inc (NTLA)

18.58
0.79
(4.44%)
Closed October 11 4:00PM
18.58
0.00
( 0.00% )
Pre Market: 7:12AM

Intellia Therapeutics Inc Financial Summary

The current NTLA market cap is 1.89B. The company's latest EPS is USD -4.7371 and P/E is -3.92.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 13.59M11.99M-1.92M28.94M6.96M
Operating Income -136.33M-134.96M-144.62M-114M-139.04M
Net Income -123.68M-122.22M-132.16M-107.44M-146.98M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 43.1M57.99M33.05M52.12M36.28M
Operating Income -106.37M-136.58M-269.18M-469.24M-530.92M
Net Income -99.53M-134.23M-267.89M-474.19M-481.19M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.32B1.24B1.3B1.26B1.19B
Total Liabilities 218.35M205.94M250.81M223.45M220.47M
Total Equity 1.1B1.04B1.05B1.04B971.06M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 334.28M676.32M1.29B1.52B1.3B
Total Liabilities 64.4M149.25M254.22M284.53M250.81M
Total Equity 269.88M527.07M1.04B1.24B1.05B
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -199.65M-301.03M-394.09M-120.66M-178.85M
Investing -156.79M-77.29M-31.35M5.9M-18.29M
Financing 4.74M23.84M130.32M59.99M101.24M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -103.24M-49.91M-225.03M-333.29M-394.09M
Investing 25.18M-214.49M-550.78M160.31M-31.35M
Financing 76.43M371.78M736.69M582.96M130.32M
Market Cap 1.89B
Price to Earnings Ratio -3.92
Price to Sales Ratio 52.03
Price to Cash Ratio 8.32
Price to Book Ratio 1.8
Dividend Yield -

Share Statistics

Shares Outstanding 101.58M
Average Volume (1 week) 1.66M
Average Volume (1 Month) 1.65M
52 Week Change -38.07%
52 Week High 34.87
52 Week Low 17.09
Spread (Intraday) 0.41 (2.16%)

Company Info

Company Name Intellia Therapeutics Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.intelliatx.com
Industry in vitro,in vivo diagnostics (2835)

Your Recent History

Delayed Upgrade Clock